Display Settings:

Format

Send to:

Choose Destination
Trends Pharmacol Sci. 2001 Nov;22(11):565-72.

Modulation of transmitter release via presynaptic cannabinoid receptors.

Author information

  • 1Institut für Pharmakologie und Toxikologie, Universität Bonn, Reuterstr. 2b, 53113, Bonn, Germany. e.schlicker@uni-bonn.de

Abstract

Cannabis (marijuana) is not only a frequently abused drug but also has the potential for the development of useful agents for the treatment of emesis, anorexia and multiple sclerosis. In this article, the effects of modulation of transmitter release by cannabinoids in both the CNS and the PNS of various species, including humans, will be discussed. Cannabinoids inhibit neurotransmitter release via specific presynaptic cannabinoid CB1 receptors. Studies using either the CB1 receptor antagonist and inverse agonist SR141716 or CB1-receptor-deficient mice suggest that numerous presynaptic cannabinoid receptors are tonically activated by endogenous cannabinoids and/or are constitutively active. CB1-receptor-mediated inhibition of transmitter release might explain, for example, reinforcing properties and memory impairment caused by cannabinoids.

PMID:
11698100
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk